日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors

免疫检查点抑制剂和致癌病毒在实体瘤中的疗效

Mechahougui, Hiba; Royston, Léna; Vieira Gomes, Catia; Kaiser, Laurent; Koessler, Thibaud; Olivier, Timothée; Mach, Nicolas; Labidi-Galy, S Intidhar; Parikh, Kaushal; Addeo, Alfredo

Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms

作者更正:利用组合算法识别用于个性化T细胞疗法的临床相关T细胞受体

Pétremand, Rémy; Chiffelle, Johanna; Bobisse, Sara; Perez, Marta A S; Schmidt, Julien; Arnaud, Marion; Barras, David; Lozano-Rabella, Maria; Genolet, Raphael; Sauvage, Christophe; Saugy, Damien; Michel, Alexandra; Huguenin-Bergenat, Anne-Laure; Capt, Charlotte; Moore, Jonathan S; De Vito, Claudio; Labidi-Galy, S Intidhar; Kandalaft, Lana E; Dangaj Laniti, Denarda; Bassani-Sternberg, Michal; Oliveira, Giacomo; Wu, Catherine J; Coukos, George; Zoete, Vincent; Harari, Alexandre

Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.

利用组合算法鉴定具有临床意义的T细胞受体,用于个性化T细胞治疗

Pétremand Rémy, Chiffelle Johanna, Bobisse Sara, Perez Marta A S, Schmidt Julien, Arnaud Marion, Barras David, Lozano-Rabella Maria, Genolet Raphael, Sauvage Christophe, Saugy Damien, Michel Alexandra, Huguenin-Bergenat Anne-Laure, Capt Charlotte, Moore Jonathan S, De Vito Claudio, Labidi-Galy S Intidhar, Kandalaft Lana E, Dangaj Laniti Denarda, Bassani-Sternberg Michal, Oliveira Giacomo, Wu Catherine J, Coukos George, Zoete Vincent, Harari Alexandre

Window of opportunity with PD1 blockade before chemoradiotherapy for an advanced stage clear cell carcinoma of the cervix

晚期宫颈透明细胞癌化疗放疗前PD-1阻断治疗的治疗窗口期

Courtès, Marie-Gabrielle; Kountouri, Melpomeni; Wang, Wenwen; Tille, Jean-Christophe; Petignat, Patrick; Undurraga, Manuela; Labidi-Galy, S Intidhar

Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature

携带 BRCA1/BRCA2 生殖系致病变异的乳腺癌和卵巢癌患者化疗的血液学毒性:单中心经验及文献回顾

Hu-Heimgartner, Ketty; Lang, Noémie; Ayme, Aurélie; Ming, Chang; Combes, Jean-Damien; Chappuis, Victor N; Vazquez, Carla; Friedlaender, Alex; Vuilleumier, Aurélie; Bodmer, Alexandre; Viassolo, Valeria; Sandoval, José L; Chappuis, Pierre O; Labidi-Galy, S Intidhar

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

出版商更正:根据分子亚型划分的BRCA1和BRCA2突变携带者乳腺癌的临床结果

De Talhouet, Solene; Peron, Julien; Vuilleumier, Aurelie; Friedlaender, Alex; Viassolo, Valeria; Ayme, Aurélie; Bodmer, Alexandre; Treilleux, Isabelle; Lang, Noemie; Tille, Jean-Christophe; Chappuis, Pierre O; Buisson, Adrien; Giraud, Sophie; Lasset, Christine; Bonadona, Valerie; Trédan, Olivier; Labidi-Galy, S Intidhar

Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation

在未接受过化疗的高级别浆液性卵巢癌(伴有CSMD3突变)中,帕博利珠单抗治疗可获得持续疗效。

Terzic, Julie; Seipel, Amanda; Dubuisson, Jean; Tille, Jean-Christophe; Tsantoulis, Petros; Addeo, Alfredo; Labidi-Galy, S Intidhar

Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review

子宫内膜异位症相关卵巢癌:发病机制、诊断和治疗靶点的见解——叙述性综述

Samartzis, Eleftherios P; Labidi-Galy, S Intidhar; Moschetta, Michele; Uccello, Mario; Kalaitzopoulos, Dimitrios R; Perez-Fidalgo, J Alejandro; Boussios, Stergios

High grade serous ovarian carcinomas originate in the fallopian tube

高级别浆液性卵巢癌起源于输卵管

Labidi-Galy, S Intidhar; Papp, Eniko; Hallberg, Dorothy; Niknafs, Noushin; Adleff, Vilmos; Noe, Michael; Bhattacharya, Rohit; Novak, Marian; Jones, Siân; Phallen, Jillian; Hruban, Carolyn A; Hirsch, Michelle S; Lin, Douglas I; Schwartz, Lauren; Maire, Cecile L; Tille, Jean-Christophe; Bowden, Michaela; Ayhan, Ayse; Wood, Laura D; Scharpf, Robert B; Kurman, Robert; Wang, Tian-Li; Shih, Ie-Ming; Karchin, Rachel; Drapkin, Ronny; Velculescu, Victor E